Carbamazepine, diclofenac, ibuprofen and bezafibrate - investigations on the behaviour of selected pharmaceuticals during wastewater treatment

Water Science and Technology

Volumn 50, Issue 5, 2004, Pages 269-276

  Strenn, B ^a   Clara, M ^a   Gans, O ^b   Kreuzinger, Norb ^a  

^a VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

^b ENVIRONMENT AGENCY AUSTRIA   (Austria)

Author keywords

Bezafibrate; Carbamazepine; Diclofenac; Ibuprofen; Sewage treatment plant; Sludge retention time

Indexed keywords

DISEASE CONTROL; DRUG PRODUCTS; RECLAMATION; SEWAGE; SURFACE WATERS; WATER TREATMENT PLANTS;

AQUATIC ENVIRONMENT; PHARMACEUTICALLY ACTIVE COMPOUNDS (PHAC); SEWAGE TREATMENT PLANTS (STP); SLUDGE RETENTION TIME (SRT);

WASTEWATER TREATMENT;

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIINFLAMMATORY AGENT; BEZAFIBRATE; CARBAMAZEPINE; DICLOFENAC; IBUPROFEN; SURFACE WATER;

ACTIVATED SLUDGE; PHARMACEUTICAL INDUSTRY; POLLUTANT REMOVAL; WASTEWATER TREATMENT;

AQUATIC ENVIRONMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EFFLUENT; ENVIRONMENTAL PROTECTION; EUROPE; SEWAGE TREATMENT PLANT; SLUDGE; STREAM (RIVER); VALIDATION PROCESS; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT;

EID: 5444220713     PISSN: 02731223     EISSN: None     Source Type: Journal    
DOI: 10.2166/wst.2004.0337     Document Type: Article

References (14)

1. Clara, M., Strenn, B., Gans, O. and Kreuzinger, N. (2003). The elimination of selected pharmaceuticals in wastewater treatment - lab scale experiments with different sludge retention times. In Water Resources Management II, International Series on Progress in Water Resources, C.A. Brebbia (ed.), WIT Press, Southampton. 227-236.
2. EN-ISO-9887 (1994). Water Quality - Evaluation of the aerobic biodegradability of organic compounds in an aqueous medium - Semi-continuous activated sludge method (SCAS) (ISO 9887:1992), German version EN ISO 9887:1994. Deutsche Einheitsverfahren L28, Beuth Verlag GmbH und VCH Verlagsgesellschaft Weinheim, Germany.
3. Heberer, T. (2002). Tracking persistent pharmaceutical residues from municipal sewage to drinking water. Journal of Hydrology 266, pp. 175-189.
4. Heberer, T., Verstraeten, I. M., Meyer, M.T., Mechlinski, A. and Reddersen, K. (2001). Occurrence and fate of pharmaceuticals during bank filtration - preliminary results from investigations in Germany and the United States. Water Resources Update 120, pp. 4-17.
5. Jorgensen, S.E. and Hailing-Sorensen, B. (2000). Drugs in the environment. Chemosphere, 40(7), 691-699.
6. POSEIDON (2002). EU funded project POSEIDON (EVK1-2000-00546), Periodic Report: January 1st, 2002-June 31st, 2002.
7. Sattelberger, R. (1999). Arzneimittelrückstände in der Umwelt. Bestandsaufnahme und Problemdarstellung. Umweltbundesamt Wien, Report 162.
8. Scharf, S., Gans, O. and Sattelberger, R. (2002). Arzneimittelwirkstoffe im Zu- und Ablauf von Kläranlagen. Umweltbundesamt Wien, Report UBA-BE-201.
9. Stan, H.J. and Heberer, T. (1997). Pharmaceuticals in the aquatic environment. Analysis Magazine, 25(7), 24-23.
10. Strenn, B., Clara, M., Gans, O. and Kreuzinger, N. (2003). The Comportment of Selected Pharmaceuticals in Sewage Treatment Plants. In Water Pollution VII, Modelling, Measuring and Prediction, Brebbia, C.A. (ed.), Almorza, D., Sales, D., WIT Press, Southampton, 273-282.
11. Stumpf, M., Ternes, T.A., Haberer, K and Baumann, W. (1998). Isolierung von Ibuprofen-Metaboliten und deren Bedeutung als Kontaminanten in der aquatischen Umwelt. [Isolation of ibuprofen-metabolites and their importance as pollutants of the aquatic environment]. Vom Wasser, 91, pp. 291-303.
12. Ternes, T.A., (1998). Occurrence of drugs in German sewage treatment plants and rivers. Water Research, 32(11), 3245-3260.
13. Ternes, T.A. (2001). Vorkommen von Pharmaka in Gewässern. Wasser & Boden, 53(4), 9-14.
14. Zwiener, C., Gremm, T.J. and Frimmel, F.H. (2001). Pharmaceutical Residues in the Aquatic Environment and their Significance for Drinking Water Production. In: Pharmaceuticals in the Environment Klaus Kümmerer (ed.), Springer-Verlag Berlin Heidelberg New York, ISBN 3-540-41067-8, pp. 81-89.